Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Sah, Birendra K ^a   Chen, Ming Min ^a   Yan, Min ^a   Zhu, Zheng Gang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHEST INFECTION; CHYLE LEAK; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FEMALE; GASTRECTOMY BILLROTH I; GASTRECTOMY BILLROTH II; HEART DISEASE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OPERATION DURATION; PANCREAS FISTULA; PANCREATITIS; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE FEVER; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE HYPOTENSION; POSTOPERATIVE INFECTION; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SEROPERITONEUM; STOMACH CANCER; STOMACH PARESIS; SURGICAL INFECTION; SURGICAL MORTALITY; TOTAL PARENTERAL NUTRITION; UPPER GASTROINTESTINAL BLEEDING; URINARY TRACT INFECTION; WOUND DEHISCENCE; ECONOMICS; GASTRECTOMY; GASTROENTEROSTOMY; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; STOMACH TUMOR;

ADULT; AGED; FEMALE; GASTRECTOMY; GASTROENTEROSTOMY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; STOMACH NEOPLASMS;

EID: 73149111736     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-428     Document Type: Article

References (34)

1. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy -- Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004, 22:2767-2773. 10.1200/JCO.2004.10.184, 15199090.
2. Swan R, Miner TJ. Current role of surgical therapy in gastric cancer. World J Gastroenterol 2006, 12:372-379.
3. Kodera Y. The beginning of a new era: East meets West more comfortably regarding lymphadenectomy for gastric cancer -- Japan will finally drop the surgery-alone arm in its pursuit of a multimodal treatment strategy. Gastric Cancer 2007, 10:69-74. 10.1007/s10120-007-0423-x, 17577614.
4. Roviello F, Marrelli D, Morgagni P, de Manzoni G, Di Leo A, Vindigni C, Saragoni L, Tomezzoli A, Kurihara H, . Italian Research Group for Gastric Cancer Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study. Ann Surg Oncol 2002, 9:894-900. 10.1007/BF02557527, 12417512.
5. Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B. Extended lymph node dissection without routine splenopancreatectomy for treatment of gastric cancer: Low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 2006, 93:394-400. 10.1002/jso.20495, 16550575.
6. Pedrazzani C, Marrelli D, Rampone B, De Stefano A, Corso G, Fotia G, Pinto E, Roviello F. Postoperative complications and functional results after subtotal gastrectomy with Billroth II reconstruction for primary gastric cancer. Dig Dis Sci 2007, 52:1757-1763. 10.1007/s10620-006-9655-6, 17404848.
7. Ichikura T, Chochi K, Sugasawa H. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer. Arch Surg 2005, 390:397-402.
8. Lo SS, Wu CW, Shen KH, Hsieh MC, Lui WY. Higher Morbidity and Mortality after Combined Total Gastrectomy and Pancreaticosplenectomy for Gastric Cancer. World J Surg 2002, 26:678-682. 10.1007/s00268-001-0289-8, 12053218.
9. Yasuda K, Shiraishi N, Adachi Y. Risk factors for complications following resections of large gastric cancer. Br J Surg 2001, 88:873-877. 10.1046/j.0007-1323.2001.01782.x, 11412261.
10. Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, Roviello F. Complications after Extended (D2) and Super extended (D3) Lymphadenectomy for Gastric Cancer: Analysis of Potential Risk Factors. Ann Surg Oncol 2007, 14:25-33. 10.1245/s10434-006-9063-3, 17024558.
11. Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, Puolakkainen P. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg 2007, 96:35-40.
12. Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata S, Yamamoto H, Kim BS, Matsuki N, Sawa T, Noh SH, . East Asia Surgical Oncology Group Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 2006, 53:389-94.
13. Hyung WJ, Kim SS, Choi WH, Cheong JH, Choi SH, Kim CB, Noh SH. Changes in Treatment Outcomes of Gastric Cancer Surgery Over 45 Years at A Single Institution. Yonsei Med J 2008, 49:409-415. 10.3349/ymj.2008.49.3.409, 2615336, 18581590.
14. Sah BK, Zhu ZG, Chen MM, Yan M, Yin HR, Lin YZ. Gastric Cancer Surgery and its Hazards: Post operative infection is the most important complication. Hepato-Gastroenterology 2008, 55:2259-2263.
15. McCulloch P, Niita ME, Kazi H. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 2005, 92:5-13. 10.1002/bjs.4839, 15635680.
16. Wu CW, Chang IS, Lo SS, Hsieh MC, Chen JH, Lui WY, Whang-Peng J. Complications Following D3 Gastrectomy: Post Hoc Analysis of a Randomized Trial. World J Surg 2006, 30:12-16. 10.1007/s00268-005-7951-5, 16369704.
17. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE. Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346:1128-37. 10.1056/NEJMsa012337, 11948273.
18. Sah BK, Zhu ZG, Chen MM, Xiang M, Chen J, Yan M, Lin YZ. Effect of surgical work volume on postoperative complication: superiority of specialized center in gastric cancer treatment. Langenbecks Arch Surg 2009, 394:41-47. 10.1007/s00423-008-0358-7, 18584204.
19. Sah BK, Zhu ZG, Wang XY, Yang QM, Chen MM, Xiang M, Chen J, Yan M. Post-operative complications of gastric cancer surgery: female gender at high risk. Eur J Cancer Care 2009, 18:202-208.
20. Nunobe S, Okaro A, Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol 2007, 12:433-439. 10.1007/s10147-007-0706-6, 18071862.
21. Fukuhara K, Osugi H, Takada N, Takemura M, Higashino M, Kinoshita H. Reconstructive Procedure after Distal Gastrectomy for Gastric Cancer that Best Prevents Duodenogastroesophageal Reflux. World J Surg 2002, 26:1452-1457. 10.1007/s00268-002-6363-z, 12370787.
22. Csendes A, Burgos AM, Smok G, Burdiles P, Braghetto I, Díaz JC. Latest results (12-21 years) of a prospective randomized study comparing Billroth II and Roux-en-Y anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers. Ann Surg 2009, 249:189-194. 10.1097/SLA.0b013e3181921aa1, 19212169.
23. Shinoto K, Ochiai T, Suzuki T, Okazumi S, Ozaki M. Effectiveness of Roux-en-Y Reconstruction After Distal Gastrectomy Based on an Assessment of Biliary Kinetics. Surg Today 2003, 33:169-177. 10.1007/s005950300039, 12658381.
24. Kim BJ, O'Connell T. Gastroduodenostomy after gastric resection for cancer. Am Surg 1999, 65(10):905-7.
25. Schweizer W, Blunschi T, Gertsch P, Blumgart LH. Postoperative course following stomach resection: a comparison of Billroth I, Billroth II and Roux-en-Y resection-reconstruction. Schweiz Med Wochenschr 1990, 120(14):521-8.
26. Chan DC, Fan YM, Lin CK, Chen CJ, Chen CY, Chao YC. Roux-en-Y reconstruction after distal gastrectomy to reduce enterogastric reflux and helicobacter pylori infection. J Gastrointest Surg 2007, 11:1732-1740. 10.1007/s11605-007-0302-0, 17876675.
27. Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991, 78:355-60. 10.1002/bjs.1800780327, 2021856.
28. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer. N Engl J Med 2008, 359:453-62. 10.1056/NEJMoa0707035, 18669424.
29. Bonenkamp JJ, Hermans J, Sasako M, Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999, 340:908-14. 10.1056/NEJM199903253401202, 10089184.
30. Wu CW, Chang IS, Lo SS, Hsieh MC, Chen JH, Lui WY, Whang-Peng J. Complications following D3 gastrectomy: post hoc analysis of a randomized trial. World J Surg 2006, 30:12-16. 10.1007/s00268-005-7951-5, 16369704.
31. Le Blanc-Louvry I, Ducrotté P, Peillon C, Michel P, Chiron A, Denis P. Roux-en-Y limb motility after total or distal gastrectomy in symptomatic and asymptomatic patients. J Am Coll Surg 2000, 190:408-417. 10.1016/S1072-7515(99)00293-8, 10757378.
32. Le Blanc-Louvry I, Ducrotte P, Chayvialle JA, Coquerel A, Michot F, Ténière P. Distal gastrectomy and Roux-Y limb in the rat: plasma motilin, pancreatic polypeptide concentrations, and duodenojejunal motility. Dig Dis Sci 2000, 45:1525-1530. 10.1023/A:1005548524334, 11007100.
33. Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JB, Zach D, Rovati LC, Stalder GA. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989, 2(8653):12-15. 10.1016/S0140-6736(89)90255-9, 2567793.
34. Mijle HC, Beekhuis H, Bleichrodt RP, Kleibeuker JH. Transit disorders of the gastric remnant and Roux limb after Roux-en-Y gastrojejunostomy: relation to symptomatology and vagotomy. Br J Surg 1993, 80:60-64. 10.1002/bjs.1800800122, 8428297.